<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Adult non-insulin requiring <z:mp ids='MP_0002055'>diabetes</z:mp> includes latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> of adults (LADA), distinguished from type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> by the presence of islet autoantibodies </plain></SENT>
<SENT sid="1" pm="."><plain>LADA China determined the characteristics of Chinese LADA </plain></SENT>
<SENT sid="2" pm="."><plain>This nationwide, multicenter, clinic-based cross-sectional study was conducted in 46 university-affiliated hospitals in 25 Chinese cities </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 4,880 <z:hpo ids='HP_0001946'>ketosis</z:hpo>-free diabetic patients (&lt;1 year postdiagnosis, without insulin therapy for &gt;6 months, aged â‰¥30 years) had GAD antibody (GADA) and HLA-DQ genotype measured centrally with clinical data collected locally </plain></SENT>
<SENT sid="4" pm="."><plain>GADA-positive subjects were classified as LADA </plain></SENT>
<SENT sid="5" pm="."><plain>Of the patients, 5.9% were GADA positive with LADA </plain></SENT>
<SENT sid="6" pm="."><plain>LADA showed a north-south gradient </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with GADA-negative type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, LADA patients were leaner, with lower fasting C-<z:chebi fb="7" ids="16670">peptide</z:chebi> and less <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with high GADA titers are phenotypically different from those with low GADA titers, while only a higher <z:chebi fb="17" ids="39025">HDL</z:chebi> distinguished the latter from those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>HLA <z:mp ids='MP_0002055'>diabetes</z:mp>-susceptible haplotypes were more frequent in LADA, even in those with low-titer GADA </plain></SENT>
<SENT sid="10" pm="."><plain>HLA <z:mp ids='MP_0002055'>diabetes</z:mp>-protective haplotypes were less frequent in LADA </plain></SENT>
<SENT sid="11" pm="."><plain>Our study implicates universal immunogenetic effects, with some ethnic differences, in <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>Autoantibody positivity and titer could be important for LADA risk stratification and accurate therapeutic choice in clinical practice </plain></SENT>
</text></document>